Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Feb;13(2):235–237. doi: 10.1111/j.1365-2125.1982.tb01364.x

Atenolol disposition in young and elderly subjects.

P C Rubin, P J Scott, K McLean, A Pearson, D Ross, J L Reid
PMCID: PMC1402004  PMID: 7059422

Full text

PDF
235

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Castleden C. M., Kaye C. M., Parsons R. L. The effect of age on plasma levels of propranolol and practolol in man. Br J Clin Pharmacol. 1975 Aug;2(4):303–306. doi: 10.1111/j.1365-2125.1975.tb02774.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Crooks J., O'Malley K., Stevenson I. H. Pharmacokinetics in the elderly. Clin Pharmacokinet. 1976;1(4):280–296. doi: 10.2165/00003088-197601040-00003. [DOI] [PubMed] [Google Scholar]
  3. Fitzgerald J. D., Ruffin R., Smedstad K. G., Roberts R., McAinsh J. Studies on the pharmacokinetics and pharmacodynamics of atenolol in man. Eur J Clin Pharmacol. 1978 May 17;13(2):81–89. doi: 10.1007/BF00609750. [DOI] [PubMed] [Google Scholar]
  4. Klotz U., Avant G. R., Hoyumpa A., Schenker S., Wilkinson G. R. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest. 1975 Feb;55(2):347–359. doi: 10.1172/JCI107938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mason W. D., Winer N., Kochak G., Cohen I., Bell R. Kinetics and absolute bioavailability of atenolol. Clin Pharmacol Ther. 1979 Apr;25(4):408–415. doi: 10.1002/cpt1979254408. [DOI] [PubMed] [Google Scholar]
  6. Reeves P. R., McAinsh J., McIntosh D. A., Winrow M. J. Metabolism of atenolol in man. Xenobiotica. 1978 May;8(5):313–320. doi: 10.3109/00498257809060956. [DOI] [PubMed] [Google Scholar]
  7. Rubin P. C., Scott P. J., Reid J. L. Prazosin disposition in young and elderly subjects. Br J Clin Pharmacol. 1981 Sep;12(3):401–404. doi: 10.1111/j.1365-2125.1981.tb01234.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wan S. H., Koda R. T., Maronde R. F. Pharmacokinetics, pharmacology of atenolol and effect of renal disease. Br J Clin Pharmacol. 1979 Jun;7(6):569–574. doi: 10.1111/j.1365-2125.1979.tb04644.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Webster J., Hawksworth G. M., Barber H. E., Jeffers T. A., Petrie J. C. Withdrawal of long-term therapy with atenolol in hypertensive patients. Br J Clin Pharmacol. 1981 Aug;12(2):211–214. doi: 10.1111/j.1365-2125.1981.tb01202.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Yee Y. G., Rubin P., Blaschke T. F. Atenolol determination by high-performance liquid chromatography and fluorescence detection. J Chromatogr. 1979 Apr 1;171:357–362. doi: 10.1016/s0021-9673(01)95315-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES